McKesson Corporation (MCK) Competitors & Peers
The 5 companies closest to McKesson Corporation on the factors that matter — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| CAH | Competitor | $237.18 | P/E 36.1RSI 59Cap 55.5 B |
| COR | Competitor | $325.00 | P/E 23.8RSI 65Cap 62.0 B |
| HSIC | Peer | $88.08 | P/E 25.7RSI 60Cap 10.0 B |
| EBOSF | Peer | $23.75 | P/E 34.9RSI 100Cap 4.9 B |
| EBOSY | Peer | $26.00 | P/E 17.7RSI 17Cap 2.7 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Confirmed relationships (cited)
Sourced from a public filing or disclosure — each links to its origin.
- BDXSupplier
McKesson is a primary distributor of BD's medical-surgical devices, consumables, and laboratory supplies to hospitals and clinics across North America.
Confirmed — SEC filing / public disclosuresec.gov ↗ - LLYSupplier
McKesson is Eli Lilly's largest wholesale distributor, representing approximately 42% of consolidated gross revenues in FY2025.
Confirmed — SEC filing / public disclosuresec.gov ↗ - BMYSupplier
McKesson is Bristol-Myers Squibb's largest wholesale distributor, accounting for approximately 42% of gross revenues in FY2025.
Confirmed — SEC filing / public disclosuresec.gov ↗ - DXCMSupplier
McKesson is a primary wholesaler and distributor for DexCom's CGM systems in the United States, representing more than 10% of DexCom's consolidated revenue.
Confirmed — SEC filing / public disclosureinvestors.dexcom.com ↗ - ORGOCustomer
McKesson acts as a key distributor for Organogenesis, representing approximately 42% of gross revenues in FY2025.
Confirmed — SEC filing / public disclosuresec.gov ↗ - ABBVSupplier
McKesson is one of AbbVie's three primary U.S. wholesalers that collectively distribute substantially all U.S. pharmaceutical sales (no individual wholesaler exceeds 39% of U.S. gross revenues).
Confirmed — SEC filing / public disclosuresec.gov ↗ - AMGNSupplier
McKesson is one of Amgen's primary pharmaceutical wholesale distributors, individually accounting for over 10% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - JNJSupplier
McKesson is JNJ's largest wholesale distributor, representing approximately 21.8% of consolidated gross revenues.
Confirmed — SEC filing / public disclosuresec.gov ↗ - GILDSupplier
McKesson is one of Gilead's three primary wholesale distributors, accounting for approximately 20-21% of Gilead's revenues.
Confirmed — SEC filing / public disclosuresec.gov ↗ - AMPHSupplier
Own 10-K customer-concentration disclosure: McKesson = 25% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - RIGLSupplier
Own 10-K customer-concentration disclosure: MckessonSpecialtyCareDistributionCorporation = 45% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - CHRSSupplier
Own 10-K customer-concentration disclosure: McKesson = 42% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - AKBASupplier
Own 10-K customer-concentration disclosure: McKessonCorporation = 12% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - ARDXSupplier
Own 10-K customer-concentration disclosure: McKessonCorporation = 14% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - VTRSSupplier
Own 10-K customer-concentration disclosure: MckessonCorporation = 10% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - CVSSupplier
McKesson is CVS Health's primary pharmaceutical distributor, supplying mail-order, specialty, and retail pharmacies. CVS represents 24% of McKesson's consolidated revenues.
Confirmed — SEC filing / public disclosuresec.gov ↗ - APYXSupplier
Own 10-Q customer-concentration disclosure: McKesson = 16% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - EYPTSupplier
Own 10-K customer-concentration disclosure: McKessonSpecialtyCareDistributionLLC = 40% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - SUPNSupplier
Own 10-Q customer-concentration disclosure: McKesson = 20% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - CELG-RISupplier
Own 10-K customer-concentration disclosure: MckessonCorporation = 34% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - MGNXSupplier
Own 10-K customer-concentration disclosure: McKessonPlasmaBiologicsAndMcKessonSpecialtyCareDistributionLLC = 12% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - EXELSupplier
Own 10-Q customer-concentration disclosure: AffiliatesofMcKessonCorporation = 18% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - MRKSupplier
McKesson is one of Merck's primary wholesale distributors for pharmaceutical products in the US.
Confirmed — SEC filing / public disclosuresec.gov ↗ - PFESupplier
McKesson is one of Pfizer's primary pharmaceutical wholesale distributors in the US, distributing the majority of Pfizer's branded and biosimilar products.
Confirmed — SEC filing / public disclosuresec.gov ↗
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- HCAPartner
McKesson and HCA Healthcare formed a strategic joint venture combining McKesson's US Oncology Research (USOR) and HCA's Sarah Cannon Research Institute (SCRI) to expand clinical trials and oncology research. McKesson holds a 51% controlling interest.
Model-inferred, unverified — treat as a lead, not evidence - CORCompetitor
Top 3 US drug distributors.
Model-inferred, unverified — treat as a lead, not evidence - CAHCompetitor
Top 3 US drug distributors.
Model-inferred, unverified — treat as a lead, not evidence - PENSupplier
McKesson acts as a wholesale distributor of Penumbra's thrombectomy and neurovascular devices to hospital systems.
Model-inferred, unverified — treat as a lead, not evidence - NVOSupplier
McKesson is Novo Nordisk's largest US wholesale distributor, representing approximately 23% of total global net sales in 2024.
Model-inferred, unverified — treat as a lead, not evidence - ABTSupplier
McKesson is a primary healthcare distributor of Abbott's diagnostics, medical devices, and nutritional products to healthcare providers.
Model-inferred, unverified — treat as a lead, not evidence - MDTSupplier
McKesson is a major wholesale distributor of Medtronic's clinical and surgical devices to hospitals.
Model-inferred, unverified — treat as a lead, not evidence - EWSupplier
McKesson is a major wholesale distributor of Edwards' structural heart devices and surgical valve components.
Model-inferred, unverified — treat as a lead, not evidence - BSXSupplier
McKesson serves as a major wholesale distributor of Boston Scientific's medical devices to hospitals and clinics.
Model-inferred, unverified — treat as a lead, not evidence - SYKSupplier
McKesson is a primary wholesale distributor of Stryker's medical devices and surgical instruments to hospitals and healthcare systems.
Model-inferred, unverified — treat as a lead, not evidence - ZBHSupplier
McKesson distributes Zimmer Biomet's medical equipment, accessories, and orthopaedic products to surgical centers and hospitals across North America.
Model-inferred, unverified — treat as a lead, not evidence - SNNSupplier
McKesson is a key distributor of Smith & Nephew's wound care, sports medicine, and surgical devices to hospitals, ambulatory surgery centers, and specialty clinics.
Model-inferred, unverified — treat as a lead, not evidence - IARTSupplier
McKesson Medical-Surgical serves as a major distributor for Integra's specialized surgical instruments and wound care product lines.
Model-inferred, unverified — treat as a lead, not evidence - ALMCustomer
McKesson distributes Alimera's ILUVIEN implants to US clinics.
Model-inferred, unverified — treat as a lead, not evidence - ORGOSupplier
McKesson acts as a major medical-surgical distributor helping fulfill ORGO's product distribution.
Model-inferred, unverified — treat as a lead, not evidence - JNJSupplier
McKesson distributes J&J pharmaceuticals.
Model-inferred, unverified — treat as a lead, not evidence - MRKSupplier
McKesson is Merck distributor.
Model-inferred, unverified — treat as a lead, not evidence - PFESupplier
McKesson is among Pfizer's largest US pharma distributors.
Model-inferred, unverified — treat as a lead, not evidence - REGNSupplier
McKesson is one of Regeneron's primary pharmaceutical wholesale distributors in the US, distributing Eylea, Dupixent, and other products.
Model-inferred, unverified — treat as a lead, not evidence - UNHPartner
McKesson supplies pharmaceuticals to Optum Rx, UNH's PBM subsidiary that manages prescription benefits for UNH's 49.8M members.
Model-inferred, unverified — treat as a lead, not evidence - OGNCustomer
McKesson is a key wholesale distributor routing Organon products to retail pharmacies and hospitals.
Model-inferred, unverified — treat as a lead, not evidence - VRTXSupplier
McKesson is one of Vertex's primary wholesale distributors for its cystic fibrosis medicines (Trikafta/Kaftrio) in the US.
Model-inferred, unverified — treat as a lead, not evidence - RADSupplier
McKesson distributes to Rite Aid (post-bankruptcy emerge).
Model-inferred, unverified — treat as a lead, not evidence